PNC Financial Services Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,360
Closed -$1.05M 5215
2025
Q4
$1.05M Sell
10,360
-622
-6% -$50K ﹤0.01% 1238
2025
Q3
$601K Sell
10,982
-857
-7% -$42.8K ﹤0.01% 1526
2025
Q2
$629K Buy
11,839
+478
+4% +$24.3K ﹤0.01% 1405
2025
Q1
$492K Buy
11,361
+77
+0.7% +$3.9K ﹤0.01% 1528
2024
Q4
$634K Sell
11,284
-69
-0.6% -$4.29K ﹤0.01% 1382
2024
Q3
$773K Sell
11,353
-562
-5% -$31.7K ﹤0.01% 1282
2024
Q2
$503K Sell
11,915
-4,071
-25% -$224K ﹤0.01% 1481
2024
Q1
$1.1M Sell
15,986
-2,205
-12% -$139K ﹤0.01% 1118
2023
Q4
$1.35M Buy
18,191
+4,258
+31% +$279K ﹤0.01% 1020
2023
Q3
$951K Sell
13,933
-2,466
-15% -$209K ﹤0.01% 1137
2023
Q2
$1.54M Sell
16,399
-1,799
-10% -$140K ﹤0.01% 969
2023
Q1
$1.23M Buy
18,198
+1,174
+7% +$75.5K ﹤0.01% 1042
2022
Q4
$843K Sell
17,024
-4,106
-19% -$168K ﹤0.01% 1226
2022
Q3
$685K Buy
21,130
+1,141
+6% +$47K ﹤0.01% 1328
2022
Q2
$787K Buy
19,989
+4,039
+25% +$216K ﹤0.01% 1288
2022
Q1
$1.11M Buy
15,950
+156
+1% +$11.4K ﹤0.01% 1178
2021
Q4
$1.23M Buy
15,794
+4,374
+38% +$386K ﹤0.01% 1171
2021
Q3
$1.09M Buy
11,420
+134
+1% +$14.1K ﹤0.01% 1154
2021
Q2
$1.4M Sell
11,286
-328
-3% -$39.1K ﹤0.01% 1059
2021
Q1
$1.53M Buy
11,614
+7,863
+210% +$1.08M ﹤0.01% 993
2020
Q4
$496K Buy
3,751
+312
+9% +$37.7K ﹤0.01% 1491
2020
Q3
$350K Sell
3,439
-169
-5% -$14.6K ﹤0.01% 1581
2020
Q2
$313K Buy
3,608
+161
+5% +$12.9K ﹤0.01% 1657
2020
Q1
$200K Buy
3,447
+447
+15% +$36.3K ﹤0.01% 1820
2019
Q4
$278K Sell
3,000
-55
-2% -$4.83K ﹤0.01% 1861
2019
Q3
$277K Buy
3,055
+872
+40% +$99.4K ﹤0.01% 1949
2019
Q2
$258K Sell
2,183
-275
-11% -$27.7K ﹤0.01% 2017
2019
Q1
$213K Sell
2,458
-239
-9% -$20.3K ﹤0.01% 2111
2018
Q4
$170K Sell
2,697
-11,756
-81% -$807K ﹤0.01% 2157
2018
Q3
$1.14M Sell
14,453
-17,235
-54% -$1.12M ﹤0.01% 1278
2018
Q2
$1.89M Sell
31,688
-8,163
-20% -$439K ﹤0.01% 1070
2018
Q1
$1.61M Sell
39,851
-2,197
-5% -$107K ﹤0.01% 1110
2017
Q4
$2.21M Buy
42,048
+13,746
+49% +$734K ﹤0.01% 1003
2017
Q3
$1.33M Sell
28,302
-18,673
-40% -$752K ﹤0.01% 1178
2017
Q2
$1.66M Sell
46,975
-1,355
-3% -$41.8K ﹤0.01% 1068
2017
Q1
$1.14M Sell
48,330
-26,181
-35% -$519K ﹤0.01% 1228
2016
Q4
$996K Buy
74,511
+66,111
+787% +$1.07M ﹤0.01% 1288
2016
Q3
$156K Sell
8,400
-690
-8% -$12.2K ﹤0.01% 2228
2016
Q2
$111K Buy
9,090
+3,981
+78% +$30K ﹤0.01% 2417
2016
Q1
$34K Buy
5,109
+17
+0.3% +$109 ﹤0.01% 3003
2015
Q4
$46K Sell
5,092
-10,800
-68% -$100K ﹤0.01% 2875
2015
Q3
$287K Sell
15,892
-38,205
-71% -$878K ﹤0.01% 1885
2015
Q2
$1.61M Buy
54,097
+10,263
+23% +$258K ﹤0.01% 1066
2015
Q1
$966K Buy
43,834
+1,200
+3% +$30.4K ﹤0.01% 1275
2014
Q4
$1.17M Buy
42,634
+40,766
+2,182% +$992K ﹤0.01% 1131
2014
Q3
$37K Sell
1,868
-400
-18% -$7.33K ﹤0.01% 2827
2014
Q2
$39K Buy
2,268
+800
+54% +$11K ﹤0.01% 2679
2014
Q1
$20K Buy
1,468
+840
+134% +$11.3K ﹤0.01% 2851
2013
Q4
$7K Hold
628
﹤0.01% 3071
2013
Q3
$7K Hold
628
﹤0.01% 3349
2013
Q2
$9K Buy
+628
New +$6.82K ﹤0.01% 3170

Other funds holding EXAS

PNC Financial Services Group's EXAS Position: Q1 2026 in Review

PNC Financial Services Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 10,360 shares — an estimated $1.05M sold.

PNC Financial Services Group first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $2.21M in Q4 2017. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • PNC Financial Services Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 10,360 Exact Sciences shares in Q1 2026, an estimated $1.05M.
  • PNC Financial Services Group first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • PNC Financial Services Group's Exact Sciences position peaked at $2.21M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.